[Ulcerative colitis. Chronic active course]

Z Gastroenterol. 2004 Sep;42(9):1006-10. doi: 10.1055/s-2004-813495.
[Article in German]
No abstract available

MeSH terms

  • Administration, Oral
  • Adult
  • Age Factors
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use
  • Azathioprine / administration & dosage
  • Azathioprine / adverse effects
  • Azathioprine / therapeutic use
  • Child
  • Chronic Disease
  • Ciprofloxacin / administration & dosage
  • Ciprofloxacin / therapeutic use
  • Colectomy
  • Colitis, Ulcerative* / diagnosis
  • Colitis, Ulcerative* / drug therapy
  • Colitis, Ulcerative* / surgery
  • Colitis, Ulcerative* / therapy
  • Controlled Clinical Trials as Topic
  • Diabetes Mellitus
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Magnetic Resonance Imaging
  • Male
  • Mercaptopurine / administration & dosage
  • Mercaptopurine / therapeutic use
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use
  • Nutritional Physiological Phenomena
  • Pregnancy
  • Recurrence
  • Remission Induction
  • Risk Factors
  • Time Factors

Substances

  • Anti-Infective Agents
  • Immunosuppressive Agents
  • Ciprofloxacin
  • Mercaptopurine
  • Azathioprine
  • Methotrexate